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A growing body of research has uncovered that acetaminophen, the most commonly 
used over-the-counter painkilling drug in the United States, produces a number of 
unintended psychological effects. In particular, recent studies show that 
acetaminophen blunts a variety of adaptive affective and cognitive processes, 
including our sensitivity to painful social experiences and subjective responses to 
emotional stimuli. Using a double-blind placebo-controlled study, here we examined 
whether acetaminophen alters the early visual processing of emotional facial 
expressions. Participants consumed 1000 mg of acetaminophen, or a matched 
placebo, prior to performing a delayed disengagement task with different facial 
expressions. Specifically, we used eye-tracking software to assess the latency to look 
away from neutral, happy, and angry faces. Based on prior research, we hypothesized 
that acetaminophen would reduce the typical delay in disengaging from emotional 
expressions. Our findings showed a significant main effect of facial expression, with 
happy faces producing the greatest delay, but there was no difference in response 
between the acetaminophen and placebo conditions. These results indicate that 
acetaminophen does not alter our initial assessment of emotional facial expressions, 
but we suggest further research be conducted to examine how this widely consumed 
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INTRODUCTION 
 
Medicinal drugs generally offer major health and societal benefits, but they 
can also disrupt or inhibit mechanisms that promote adaptive fitness outcomes 
(Nesse & Berrdige, 1997). For example, the unpleasantness of physical pain is highly 
adaptive and critical for survival, as it draws our attention and serves to motivate 
responses to alleviate the discomfort. Therefore, the routine dulling of pain from over-
the-counter (OTC) drugs and other pain medications can produce a mismatch with 
evolved psychological mechanisms to minimize distress (Gallup, 2019). 
Acetaminophen (paracetamol, Tylenol) is the most common OTC painkiller in 
the United States, with estimates suggesting that nearly one in four adults consumes 
a medication containing acetaminophen each week (Kaufman et al., 2002). As an 
analgesic, acetaminophen is well tolerated and effective in reducing mild to moderate 
physical pain and ailments, providing relief from headaches, and reducing fever. 
Acetaminophen is a weak inhibitor of the synthesis of prostaglandins, with evidence 
suggesting that the analgesic effect results from activation of the descending 
inhibitory serotonin pathways (e.g., Graham & Scott, 2005; Pickering et al., 2008). 
While the precise mechanisms by which acetaminophen exerts an analgesic effect 
remain unclear (Graham et al., 2013), it is widely accepted that this drug reduces pain 
through central, rather than peripheral, nervous system mechanisms (Anderson, 
2008; Courade et al., 2001; Pickering et al., 2006; Smith, 2009). The central activation 
of acetaminophen means it could also produce varied psychoactive effects, i.e., 
alterations in other forms of perception, mood, cognition and behavior. In general, 
psychoactive drugs bypass evolved information processing systems governing 
behavior and emotions, thus potentially disengaging otherwise adaptive 
psychological mechanisms and defenses (Nesse & Berrdige, 1997).  
In the first study to examine the potential unintended psychological effects of 
this drug, DeWall et al. (2010) investigated whether acetaminophen altered feelings 
of psychosocial distress. This work was based on prior neuroimaging research 
showing that both physical and social pain are processed within the same 
neurobiological systems, i.e., dorsal anterior cingulate cortex and anterior insula 
(Apkarian et al., 2005; Eisenberger et al., 2003; Peyron et al., 2000; Rainville et al., 
1997). Therefore, the researchers predicted that acetaminophen would reduce social 
pain by attenuating neural activity within these critical brain regions. It was found that 
after taking 1,000-2,000 mg of acetaminophen daily for a period of three weeks, 
participants indeed reported significantly lower levels of social pain in their daily lives 
and showed reduced neural activation in both the dorsal anterior cingulate cortex and 
anterior insula to social rejection scenarios produced in a laboratory setting (DeWall 
et al., 2010).  
Subsequent research has now expanded upon these initial findings (Fung & 
Alden 2017; Slavich et al. 2019), and a growing number of studies have confirmed 
that even a single 1,000 mg dose of acetaminophen can reduce varied forms of 
psychosocial distress. In one study, acetaminophen interrupted typical compensatory 
responses to violations of expectations, also known as meaning threats (Randles et 
al., 2013). For example, participants given an acute dose of acetaminophen (1,000 
mg) experienced less negativity when thinking about their own mortality compared to 
placebo. Single doses of acetaminophen have also been shown to reduce internal 
Acetaminophen and the Processing of Facial Expressions 
 
EvoS Journal: The Journal of the Evolutionary Studies Consortium 
ISSN: 1944-1932 - http://evostudies.org/evos-journal/about-the-journal/  
2020, NEEPS XIII, pp. 34-43.                                                                                                          -36- 
conflict and pain associated with some forms of decision-making (DeWall et al., 2015) 
as well as reduce the perceived challenge associated with tasks designed to induce 
social stress (Bershad et al., 2018).  
Acetaminophen has even been shown to reduce empathy for the pain and 
suffering experienced by others (Mischkowski et al., 2016). In particular, participants 
administered 1,000 mg of acetaminophen showed reduced personal distress, 
perceived pain, and empathic concern to hypothetical and laboratory-based scenarios 
in which individuals experienced both physical and social pain. In a follow-up to this 
research, the same single dose of acetaminophen also reduced affective reactivity to 
the positive experiences of others (i.e., positive empathy: Mischkowski et al., 2019). 
Recent research has also examined the influence of acetaminophen on social 
economic interactions (Roberts et al., 2018; 2019). For example, participants with 
elevated personality disorder features showed less trust compared to others when 
administered a placebo, but showed increased trust (i.e., reduced distrust) when 
given acetaminophen (Roberts et al., 2018).  
Related research indicates that acute doses of acetaminophen can inhibit 
general forms of evaluative processing through the widespread blunting of cortical 
activity. In one study, participants were administered either acetaminophen or 
placebo and asked to rate the positive or negative valence of a series of images, and 
to respond to how much the images elicited an emotional reaction (Durso et al., 2015). 
Results revealed that participants in the acetaminophen condition rated both positive 
and negative images less extremely and less emotionally arousing than those in the 
control condition. Consistent with these findings, recent electroencephalography 
(EEG) studies have demonstrated that acetaminophen disrupts evaluative processing 
in the cortex (Randles et al., 2016) and neurocognitive disengagement during off-task 
attentional states (Mutti et al., 2019). Despite the growing interest in this area, there 
are many unresolved and open questions regarding the psychological and 
neurological effects of this commonly used OTC drug (Ratner et al., 2018).  
Extending upon these recent findings, here we investigate whether 
acetaminophen disrupts the early processing of emotional signals. Past research has 
shown an evolved tendency for humans to prioritize and automatically orient towards 
emotional facial expressions (Öhman et al., 2001; Öhman, 2002; Vuilleumier & 
Schwartz, 2001). For example, happy and angry faces tend to capture and hold our 
attention (Mack et al., 2002; Torrence et al., 2017). Therefore, the current study tested 
whether acetaminophen modulates the initial visual processing of emotional facial 
expressions using a delayed disengagement task (e.g., Belopolski et al., 2011). Given 
previous research demonstrating that acute doses of acetaminophen diminish 
affective responses to both positive and negative stimuli (DeWall et al., 2010; Durso 
et al., 2015; Michkowski et al., 2016; 2019), we hypothesized that the administration 





Participants. A total of 101 (32 female) college students participated in a 
study investigating the effects of acetaminophen on various aspects of psychological 
processing from November 2018 to May 2019. Recruitment occurred through the 
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psychology pool and campus flyers on a public research university in Upstate New 
York. The data from one participant was removed upon discovering they were 17 
years of age. The remaining sample was aged 18-34 years (mean ± SD: 19.61 ± 
2.71). Participants received either course research credit or $20 in compensation for 
their time in the study. Exclusion criteria included any risk factors associated with 
taking acetaminophen (e.g., currently taking a drug containing acetaminophen, a 
history of liver disorder, an allergic reaction to acetaminophen or a history of alcohol 
abuse) or a history of medical or psychiatric illness. The experiment was conducted 
in accordance with approved human ethics guidelines, and all participants provided 
informed consent prior to partaking in this study. The local Institutional Review Board 
approved this research (#2018-08-07-1). 
 Design. Random assignment determined whether participants consumed a 
10 ml liquid containing 1,000 mg of acetaminophen or a matched placebo solution. 
Similar to Michkowski et al. (2016), acetaminophen and placebo solutions were 
prepared by Pharmacy Specialists Compounding Pharmacy (Altamonte Springs, 
Florida). The drug solution consisted of acetaminophen (100 mg/ml) dissolved in Ora-
Plus suspension liquid and flavored with Ora-Sweet Syrup and the placebo solution 
will consist of Avicel Microcrystalline powder (100 mg/ml) dissolved in the same 
vehicle. Participants and researchers were blind to the experimental condition. 
Participants were asked to refrain from eating for at least three hours prior to the 
study, and following administration participants waited for a period of 60 minutes for 
drug absorption (Randles et al., 2013; Durso et al., 2015).  
Following the waiting period, participants were escorted to a cubicle and 
positioned at a desk approximately 65cm from a Tobii Pro Spectrum 150hz eye-
tracker attached to a 60cm stimulus presentation monitor (EIZO FlexScan EV2451). 
Following a standard 5-point calibration to assess accuracy and precision, 
participants were instructed on how to perform a delayed disengagement task 
modified from Belopolski et al. (2011). Specifically, participants were cued to the 
center of the screen and then presented with a face positioned in between two target 
boxes (one on the left; one on the right). The faces were 200 x 300 pixels at their 
greatest dimensions (approximately 4.8 degrees of visual angle wide and 7.1 degrees 
of visual angle high), and the offset target boxes were 300 x 300 pixels (approximately 
6.3 degrees of visual angle wide and 6.3 degrees of visual angle high). Each trial 
started with a fixation point at the center of the screen for 1350 ms, which was followed 
by a face at the fixation point for 2000 ms and then a blank screen for 350 ms (Figure 
1). Face stimuli included closed mouth depictions of neutral, happy, and angry 
expressions from the NimStim face set (Tottenham et al., 2009). These images were 
modified to grayscale and a uniform oval shape (which also removed hairstyles). Each 
face was tilted 10o on the vertical axis, and participants were instructed to look at the 
box in the congruent direction of the tilted face as quickly as possible. Hence, if the 
face was tilted to the left, participants had to fixate on the box on the left (see Figure 
1). Both boxes included a target dot which was 742 pixels from the center of the 
screen. A predefined area of interest (AOI) was drawn over each of the boxes 
(overlapping the edges by 50 pixels, or approximately 13.4 mm), and responses were 
measured by the latency (in milliseconds) to fixate on the AOI of the congruent box. 
Participants were informed that the expression of the face was irrelevant to the task. 
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Figure 1. Depiction of the focal point and stimulus presentation for the delayed disengagement 
task. Represented above is an angry female face tilted to the left; during this trial, participants 
would avert their attention and fixate on the left box as quickly as possible. 
 
Prior to testing, participants completed 12 practice trials to become familiar 
with the task. These trials portrayed one male face and one female face in all possible 
combinations (3 expressions x 2 vertical orientations), and participants received 
verbal feedback on their performance from a researcher running the session from the 
other side of a partition. Following the practice trials, participants then completed 96 
testing trials separated by a break at the midpoint. These trials portrayed eight male 
and eight female faces in all possible combinations, with the order randomized prior 
to testing. Participants were encouraged to respond as quickly and accurately as 
possible during all trials. 
Analysis. During data collection, five participants indicated having an eye 
condition and/or produced high inaccuracy or imprecision during calibration, and 
therefore were not included in the analysis. In addition, based on research indicating 
the time needed before a programed eye movement is launched (e.g., Matin et al., 
1993), any trial responses that occurred before 200 ms were excluded from the 
analysis. Moreover, the data from an entire participant were excluded from the 
analysis if the individual responded too early (< 200 ms) or too late (> 2000 ms) on 
more than five of the 96 trials during testing. This included 5% of the total sample 
(5/100).  
The final sample consisted of 90 participants (43 acetaminophen; 47 placebo), 
all with normal or corrected to normal vision. We ran a mixed-effect ANOVA with facial 
expression (neutral, angry, or happy) as a within-subject factor and drug treatment 
(acetaminophen or placebo) as a between-subject factor. A post hoc power analysis 
was performed for this design using G*Power 3.1, indicating power of 0.846 to detect 
a small effect. All statistics were conducted in SPSS, with the alpha set to 0.05. 
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Figure 2. Fixation latencies varied significantly across the three facial expressions (p < 0.05), 






Analyses revealed a significant main effect of facial expression (F2,176 = 3.927, 
p = 0.021, partial eta2 = 0.043; Figure 2). Post hoc tests revealed that disengagement 
away from the angry faces was significantly faster compared to both happy faces (p 
= 0.008) and neutral faces (p = 0.042). However, there was absolutely no difference 
between conditions with regards to drug treatment (F1,88 = 0.000, p = 0.983, partial 
eta2 = 0.000). Moreover, there was no interaction between the facial expression and 
drug treatment conditions (F2,176 = 1.018, p = 0.364, partial eta2 = 0.011). Therefore, 





A growing number of studies have reported distinct psychological effects 
resulting from the consumption of acetaminophen (reviewed by Ratner et al., 2018). 
Based on previous work showing that acetaminophen blunts affective responses to 
positive and negative stimuli (e.g., DeWall et al., 2010; Durso et al., 2015; Michkowski 
et al., 2016; 2019), this study examined whether this drug influences the early 
processing of emotional facial expressions. Contrary to our predictions, participants 
in both the acetaminophen and placebo groups responded similarly across facial 
expression conditions.  
Prior imaging studies have shown that acetaminophen attenuates activity 
within cortical areas involved in the rapid processing of emotional facial expressions 
(i.e., the anterior cingulate cortex: DeWall et al., 2010; Fan et al., 2011; Pickering et 
al., 2015). However, a large number of cortical and subcortical structures become 
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active during the early processing of emotional faces (e.g., Adolphs, 2002; Fan et al., 
2011; Habel et al., 2007; LeDoux, 1995; Morris et al., 1999), and the null effects 
reported here may be due to greater subcortical activation during the disengagement. 
In other words, it is possible that the test we used incorporates brain areas that are 
so evolutionarily conserved, due to the necessity of quickly processing emotions via 
the face, that the neuromodulation from acetaminophen fails to alter this prewired 
adaptation. In addition, the nature of focusing on the vertical orientation of the facial 
stimuli could recruit other brain regions not affected by acetaminophen. Therefore, 
future research could more explicitly investigate whether this drug modulates the 
evaluation of more complex emotional states in others. Based on studies showing 
that acetaminophen inhibits the activation of some emotions (e.g., DeWall et al., 2010; 
Randles et al., 2013), it would also be interesting to assess whether this OTC drug 
blunts facial affect display. 
 Across drug treatment conditions, our results show that happy faces produced 
the slowest disengagement and angry faces produced the fastest disengagement. 
These findings are in contrast to those reported in Belopolski et al. (2011), which 
showed slowest disengagement from angry expressions and no difference between 
happy and neutral faces. It is not clear why our results differ, particularly given the 
backdrop of literature showing that biologically threatening stimuli capture attention 
(e.g., Öhman et al., 2001; Öhman & Mineka, 2001). However, one key distinction in 
methods is that Belopolski et al. (2011) used schematic faces with more dramatic 
cues of happiness and anger, while the current study included photographs of people 
displaying subtle, closed mouth depictions of these emotions (Tottenham et al., 
2009). Therefore, it remains possible that the more overt “open mouth stimuli” from 
the NimStim image set would produce different effects. Nonetheless, prior works have 
shown that happiness captures attention (Mack et al., 2002; Miyazawa, & Iwasaki, 
2010; Torrence et al., 2017), and the main effect observed here is consistent with this 
literature. 
 In summary, the results of this study suggest that an acute dose of 
acetaminophen does not alter the early processing of emotional facial expressions. 
However, due to limitations in the current approach, we propose that research 
continue to explore how acetaminophen may alter both the detection and perception 
of emotion in others. With tens of millions of Americans consuming acetaminophen 
each week, it is critical for researchers to study the full range of psychological effects 
produced by this drug if we hope to understand how it influences real-world 
interactions and interpersonal relationships. Moreover, further research should 
explore how chronic use of this drug may alter different aspects of 
neurological/psychological processing. In particular, we believe that further 
evolutionary inspired research like this could provide important insight into 
understanding how this common OTC painkiller produces a mismatch with our 
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